Evidence map›Paper›PMID 18083188›Full record

ArticleJournal of molecular and cellular cardiology2008

Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms.

Alfred C Nicolosi, Jennifer L Strande, Anna Hsu, Xiangping Fu, Jidong Su, Garrett J Gross, John E Baker

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alfred C NicolosiDivision of Cardiothoracic Surgery, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA. nicolosi@mcw.edu
Jennifer L Strande
Anna Hsu
Xiangping Fu
Jidong Su
Garrett J Gross
John E Baker
Medical College of Wisconsin · US

Funding

EFFECTS OF DRUGS UPON MYOCARDIAL HYPOXIAR01HL008311 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI GROSS, GARRETT JOHN · 1985 to 2009
$2.7M
NITRIC OXIDE AND TOLERANCE OF HYPOXIC HEART TO ISCHEMIAR01HL054075 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI BAKER, JOHN E · 1997 to 2010
$2.5M
NHLBI NIH HHS HL 08311NHLBI NIH HHS HL 54075NHLBI NIH HHS R01 HL008311NHLBI NIH HHS R01 HL054075
6 · The paper itself

Abstract

The lanthanide cation, gadolinium (Gd) attenuates post-ischemic myocardial stunning. This study tests the hypothesis that Gd also preconditions the myocardium against infarction following ischemia-reperfusion (IR) and explores potential mechanisms underlying Gd-induced cardioprotection. Regional myocardial infarction was induced in rats by occluding the left anterior descending artery for 30 min and reperfusing for 120 min. Rats (n=6/group) were administered intravenous Gd (1 to 100 micromol/kg) 15 min prior to ischemia. Hearts were excised after reperfusion to determine infarct size (IS) and area at risk (AAR). The ratio IS/AAR (%) was reduced by Gd in a "U"-shaped, dose-dependent manner. The minimum dose that reduced IS/AAR was 5 micromol/kg (52+/-5% vs. 64+/-4%), while the dose that reduced IS/AAR maximally was 20 micromol/kg (44+/-4%). Gd also reduced IS/AAR when given 1 min before reperfusion (47+/-3%) but not when given 10 s after reperfusion (60+/-3%). Cardioprotection was maintained if IR was delayed 24-72 h after Gd administration. Cardioprotection by Gd was abolished by inhibition of JAK-2 with AG-490, of p42/44 MAPK with PD98059 or of K(ATP) channels with glibenclamide. None of these agents given alone altered IS/AAR compared with controls. Inhibition of JAK-2 also blocked Gd-induced delayed cardioprotection. Gd may have broad potential roles in IR, as it conferred immediate cardioprotection when given prior to ischemia or prior to reperfusion and delayed cardioprotection for up to 72 h after administration. The mechanism underlying Gd-induced preconditioning appears to be multi-factorial, involving JAK-2, STAT-3 and p44 MAPK pathways, as well as K(ATP) channels.

Indexed as

AnimalsCardiotonic AgentsDose-Response Relationship, DrugGadoliniumHemodynamicsIn Vitro TechniquesJanus Kinase 2MaleMyocardial InfarctionMyocardial IschemiaPotassium ChannelsRatsRats, Sprague-DawleySTAT Transcription FactorsTime FactorsCardiotonic AgentsGadoliniumJak2 protein, ratJanus Kinase 2Potassium ChannelsSTAT Transcription Factors

Identifiers

PMID18083188
PMCPMC2322938
OpenAlexW2013045426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.